Hostname: page-component-848d4c4894-pjpqr Total loading time: 0 Render date: 2024-06-24T07:53:13.578Z Has data issue: false hasContentIssue false

A case report of schizophrenia and HIV: HAART in association with clozapine

Published online by Cambridge University Press:  01 June 2009

Sebastian Sanz-Cortés
Affiliation:
Hospital and Community Psychiatric Services, Osuna Hospital, Seville, Spain
Elena Fashho-Rodriguez
Affiliation:
Hospital and Community Psychiatric Services, Osuna Hospital, Seville, Spain
Tomás Sánchez-Araña Moreno
Affiliation:
Hospital and Community Psychiatric Services, Osuna Hospital, Seville, Spain
Sergio Ruiz-Doblado*
Affiliation:
Chairman, Psychiatric Department, Osuna Hospital
Jorge Marín-Martín
Affiliation:
Chairman, Internal Medicine Department, Osuna Hospital
*
Correspondence to: Dr Sergio Ruiz-Doblado, Servicio de Psiquiatría, Hospital de la Merced, Avda. Constitución, 2, 41640 Osuna (Sevilla), Spain. Tel & fax: +34 955 077257; E-mail: sergioruiz@ozu.es
Get access

Abstract

The anti-psychotic drug management of patients with schizophrenia and HIV-1 infection is problematic. Such individuals are prone to extra-pyramidal reactions on account of HIV-1 induced sub-cortical involvement and exacerbation of cognitive impairment due to underlying CNS infection. Compliance with treatment can be problematic due to a disordered mental state and bone marrow toxicity may also result from the combined effects of anti-psychotic and retroviral agents. It is generally thought that atypical anti-psychotic drugs are the treatment of choice in such cases.

We present the case of a 30-year-old man with a history of schizophrenia who was successfully treated with clozapine following an admission to a psychiatric unit with acute confusional symptoms secondary to HIV-related central nervous system (CNS) involvement.

Type
Case Report
Copyright
Copyright © NAPICU 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Altschuler, E.L. and Kast, R.E. (2005) The atypical antipsychotic agents ziprasidone, risperidone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Medical Hypotheses. 65: 585586.CrossRefGoogle ScholarPubMed
American Psychiatric Association Work Group on HIV/AIDS (2000) Practice Guideline for the treatment of patients with HIV/AIDS. American Journal of Psychiatry. 157 (Suppl. 11): 162.Google Scholar
Andreasen, N. (1984) The Scale for the Assessment of Positive Symptoms. Iowa City: University of Iowa College of Medicine.Google Scholar
Baum, S., Ashok, A., Gee, G., et al. (2003) Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy. Journal of Neurovirology. 9(Suppl. 1): 3237.CrossRefGoogle ScholarPubMed
Della, N.D. and Treisman, G.J. (2005) HIV/AIDS. In: Levenson, J.L. Textbook of Psychosomatic Medicine. Washington: American Psychiatric Publishing, pp. 630–631.Google Scholar
Dettling, M., Muller-Oerlinghausen, B. and Britsch, P. (1998) Clozapine treatment of HIV-associated psychosis – too much bone marrow toxicity? Pharmacopsychiatry. 31: 156157.CrossRefGoogle ScholarPubMed
Jones-Brando, L.V., Buthod, J.L., Holland, L.E., et al. (1997) Metabolites of the antipsychotic agent clozapine inhibit the replication of human immunodeficiency virus type 1. Schizophrenia Research. 25: 6370.CrossRefGoogle ScholarPubMed
Lera, G. and Zirulnik, J. (1999) Pilot study with clozapine in patients with HIV-associated psicosis and drug-induced parkinsonism. Movement Disorders. 14: 128131.3.0.CO;2-J>CrossRefGoogle Scholar
Lobo, A., Ezquerra, J., Gómez, F., et al. (1979) El Mini-Examen Cognoscitivo. Un test sencillo, práctico, para detectar alteraciones intelectuales en pacientes médicos. Actas Luso-Españolas de Neurología, Psiquiatría y Ciencias Afines. 3: 189202.Google Scholar
Sperner-Unterweger, B. (2005) Immunological aetiology of major psychiatric disorders: Evidence and therapeutic implications. Drugs. 65: 14931520.CrossRefGoogle ScholarPubMed